EsPhALL: EUDRACT-n° 2004-001647-30

An open-label study to evaluate the safety and efficacy
of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+
acute lymphoblastic leukemia (Ph+ALL)
Amendment n°1/2009 version 01.12.2009